JPH0977654A - Skin preparation for external use - Google Patents

Abstract

PROBLEM TO BE SOLVED: To obtain a skin preparation for external use having excellent skin- beautifying and whitening effect, chapped skin improving effect and darkish skin improving effect. SOLUTION: This skin preparation contains 0.1-30wt.% of a hydroquinone glucoside of formula I (R is a pentose residue, a hexose residue, an amino sugar residue, a uronic acid residue or their methylated products) and 0.01-30wt.% of a quaternary ammonium salt of formula II (R<1> to R<3> are each a 1-6C alkyl; (n) is 0 or a positive number; the sum of (n) and the total C number of R<1> to R<3> is <=8) as a low-molecular betaine. The compound of formula I is e.g. hydroquinone-D-glucose (common name: arbutin). It is prepared in the form of cosmetic, drug or quasi-drug, etc., of aqueous solution system, solubilizing system, emulsifying system, powdery system, oil liquid system, gel system, ointment system, oil/water double-layer system, water/oil/water triple-layer system, etc. The skin preparation exhibits excellent skin-beautifying and whitening effect and darkish skin improving effect by the synergistic effect attained by the combined use of the compounds of the formula I and the formula II.

Description

Detailed Description of the Invention

[0001]

TECHNICAL FIELD The present invention relates to an external preparation for skin,
More specifically, it relates to an external preparation for skin which has an excellent whitening effect, improves rough skin, and has an effect of improving dullness.

[0002]

2. Description of the Related Art Although there are some unclear points regarding the mechanism of development of skin spots, in general, melanin pigments are formed due to the presence of hormones and stimulating sugars of ultraviolet rays from the sun, which are It is thought that it will be abnormally deposited. As a method for treating such spots and bruises, a method of orally administering a large amount of a substance that suppresses melanin production (for example, vitamin C agent), a method of injecting glutathione, etc.,
Alternatively, a method of locally applying L-ascorbic acid, cysteine or the like in the form of an ointment, cream, lotion or the like has been adopted. Further, a skin external preparation containing a hydroquinone glycoside for the purpose of skin whitening effect is disclosed in JP-A-60-60.
It is disclosed in Japanese Patent Laid-Open No. 56912.

[0003]

However, although many of them have a whitening effect, they do not themselves have the effect of improving skin roughness, so they are not satisfactory as an effect of improving dull skin. .

The present invention has been made in view of the above circumstances, and an object thereof is to provide an external preparation for skin which has not only an excellent whitening effect, but also a rough skin preventing and improving effect and an excellent dullness improving effect. To provide.

[0005]

Means for Solving the Problems The inventors of the present invention have conducted extensive studies to solve the above problems, and as a result, by blending a low molecular weight betaine together with a specific glycoside of hydroquinone, not only the whitening effect is excellent. In addition, it was found that an external preparation for skin having an excellent effect of improving rough skin and an effect of improving dullness can be obtained, and the present invention has been completed.

That is, according to the present invention, a low molecular weight betaine and the following general formula (I)

[0007]

Embedded image (Wherein, R is a pentose residue, a hexose residue, an amino sugar residue,
There is provided a skin external preparation comprising a glycoside of hydroquinone represented by a uronic acid residue or a methylated product thereof.

[0008]

BEST MODE FOR CARRYING OUT THE INVENTION The skin external preparation of the present invention will be described in detail below.

The low molecular weight betaine used in the present invention may include those which form a zwitterion with an inner salt of a quaternary ammonium base, a sulfonium base, a phosphonium base or the like having a molecular weight of about 100 to 200. Molecular weight is 100 ~
The reason for setting the molecular weight to about 200 is that betaine having a molecular weight of more than 200 takes on the property of a surfactant and tends to roughen the skin, while less than 100 has a strong hydrophilicity and poor permeability to the skin. Because. In the present invention, among these low molecular weight betaines, the following general formula (I
I)

[0010]

Embedded image (In the formula, R ¹ , R ² and R ³ each independently represent an alkyl group having 1 to 6 carbon atoms; n represents 0 or a positive integer; provided that the number of carbon atoms of R ¹ , R ² and R ³ is Sum of n
And the total sum thereof is 8 or less) is preferably used.

In the above general formula (II), carbon number and n
And the total molecular weight of the nitrogen atom and the alkyl groups (R ¹ , R ² and R ³ ) and (CH ₂ ) _{n + 1} bonded to the nitrogen atom becomes relatively large, The hydrophobicity of the part increases, and as a result, the property of the quaternary ammonium salt as an amphoteric surfactant tends to become apparent, which is not preferable.

R ¹ , R ² and R ³ have 1 carbon atom
A wide range of straight or branched chain alkyl groups of ~ 6 can be used. That is, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec
-Butyl group, tert-butyl group, pentyl group, isopentyl group, neopentyl group, tert-pentyl group, hexyl group, isohexyl group, 3-methylpentyl group,
Examples thereof include a 2,2-dimethylbutyl group and a 2,3-dimethylbutyl group. These R ¹ , R ² and R ³
May be the same or different.

As a combination of the above alkyl groups, R
Reducing the carbon number of ¹ , R ² and R ³ as much as possible can reduce the property of the quaternary ammonium salt represented by the general formula (II) as an amphoteric surfactant as much as possible. It is preferable in that there is a tendency. That is, in the general formula (II), R ¹ , R ² and R ³
Is most preferably a methyl group, and trimethylglycine in which n is 0 is most preferably used. Further, the above general formula (II)
Wherein R ¹ , R ² and R ³ are all methyl groups and n is 2
.Gamma.-butyrobetaine is also preferably used. Low-molecular-weight betaine not only suppresses the stickiness of other moisturizers contained in the skin external preparation, but also has a moisturizing effect and a rough skin improving effect.

The low molecular weight betaine is preferably blended in the skin external preparation of the present invention in a proportion of 0.01 to 30% by weight, more preferably 0.1 to 10% by weight, and particularly preferably 1 to 10% by weight. Is. If it is less than 0.01% by weight, the stickiness of other moisturizers (such as mucopolysaccharides) that may be contained in the external preparation for skin cannot be suppressed sufficiently, while if it exceeds 30% by weight, the effect of the present invention is obtained. Can not be expected, and the powdery feeling is felt, and the familiarity with the skin is deteriorated.

The hydroquinone glycoside used in the present invention is represented by the above general formula (I). In the formula, R represents a pentose sugar residue, a hexose sugar residue, an amino sugar residue, a uronic acid residue, or a methylated product thereof.

Preferable examples of R being a pentose residue are R-arabinose, D-arabinose, D-xylose, D-ribose, L-xylose, L-lyxose,
Examples include D-ribulose and the like.

Preferable examples of R being a hexose residue include R-D-glucose, D-galactose, L-galactose, D-mannose, D-talose, D-fructose, L-sorbose and D-tagatose. , D-busicose, etc. are exemplified.

A preferred example of R as an amino sugar residue is R
Is D-glucosamine, D-galactosamine, sialic acid,
Examples include aminouronic acid and muramic acid.

Suitable examples of R as a uronic acid residue include:
Examples of R include D-glucuronic acid, D-galacturonic acid, D-mannuronic acid, L-iduronic acid, and L-guluronic acid.

Among these, R is D-glucose in terms of whitening effect, availability, stability, safety and the like,
This is β-bonded to hydroquinone, that is, hydroquinone-D-glucose (generic name: arbutin)
Is most preferred.

The glycoside of hydroquinone represented by the general formula (I) is 0.1 to 30% by weight in the skin external preparation of the present invention.
It is preferable to be blended in a ratio of, more preferably 1 to
It is 20% by weight. If it is less than 0.1% by weight, the effect of the present invention cannot be sufficiently exerted, while if it is 30% by weight.
Even if the amount exceeds the above range, an increase in the effect commensurate with the increase in the amount added cannot be expected.

In the external preparation for skin of the present invention, by using the glycosides of low-molecular weight betaine and hydroquinone together, the whitening effect can be obtained as compared with the case where the low-molecular weight betaine and hydroquinone glycoside are blended individually. The rough skin improving effect is remarkably improved, and an extremely excellent dullness improving effect is obtained.

The external preparation for skin of the present invention may include cosmetics, pharmaceuticals, quasi-drugs and the like applied to the outer skin.

Therefore, the dosage form is also an aqueous system, a solubilizing system (for example, lotion), an emulsifying system (for example, emulsion, cream, etc.), a powder system, an oil liquid system, a gel system, an ointment system, water-oil 2
It can take a wide variety of forms such as a layer system and a water-oil-powder trilayer system.

In addition to the above-mentioned essential components, the external preparation for skin of the present invention may appropriately contain other components usually used for external preparations for skin such as cosmetics and pharmaceuticals. For example, powder components such as titanium dioxide, mica, and talc; evening primrose oil, avocado oil, mink oil, jojoba oil, macadamia nut oil, corn oil, rapeseed oil, castor oil, sunflower oil, cacao oil, coconut oil, rice bran oil, olive oil , Lanolin, squalene and other natural animal and vegetable oils and fats; liquid paraffin, squalane, petrolatum and other hydrocarbons; paraffin wax,
Wax such as whale wax, beeswax, candelilla wax and carnauba wax; higher alcohols such as cetanol and stearyl alcohol; myristic acid, palmitic acid, stearic acid, behenic acid, isostearic acid, oleic acid, linolenic acid, linoleic acid, oxy Higher fatty acids such as stearic acid; isopropyl myristic acid, isopropyl palmitic acid, isopropyl stearic acid, 2
Esters such as glycerol ethylhexanoate; polar oils such as diethylene glycol monopropyl ether, polyoxyethylene polyoxypropylene pentaerythritol ether, polyoxypropylene butyl ether, ethyl linoleate, and other silicone oils; para-aminobenzoic acid, homomethyl-7N-acetyl Allantoylanilate, butylmethoxybenzoylmethane, di-paramethoxycinnamic acid-glyceryl mono-2-ethylhexanoate, amyl salicylate, octyl cinnamate,
Ultraviolet absorbers such as 2,4-dihydroxybenzophenone; Moisturizers such as polyethylene glycol, sorbitol, xylitol, maltitol; Thickeners such as methyl cellulose, gum arabic, polyvinyl alcohol, montmorillonite, laponite; Ethanol, 1,3-butylene Organic solvents such as glycols; Antioxidants such as butylhydroxytoluene, tocopherol, phytic acid; Benzoic acid, salicylic acid, sorbic acid, paraoxybenzoic acid alkyl esters (ethylparaben, butylparaben, etc.), antibacterial agents such as hexachlorophene Acyl sarcosine acids (eg sodium lauroyl methyl sarcosine), glutathione, citric acid, malic acid, tartaric acid,
Organic acids such as lactic acid; vitamin A and its derivatives; vitamins B ₆ hydrochloride, vitamin B ₆ tripalmitate, vitamin B ₆ dioctanoate, vitamin B ₂ and its derivatives, vitamins B ₁₂ , vitamin B ₁₅ and its derivatives, etc. Bs; ascorbic acid, ascorbic acid sulfate (salt), ascorbic acid phosphate (salt),
Vitamin Cs such as ascorbic acid dipalmitate; α-
Vitamin Es such as tocopherol, β-tocopherol, γ-tocopherol, vitamin E-acetate, vitamin E-nicotinate; vitamins such as vitamin Ds, vitamin H, pantothenic acid, pantothetin; nicotinamide, benzyl nicotinate , Γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol, thymol inositol, saponins (carrot saponin, hemimasaponin, muclodisaponin, etc.), pantoterethyl ether , Ethinyl estradiol, tranexamic acid, cephalandin,
Various agents such as placenta extract; Rumex, Clara, Kohone, orange, sage, saw grass, mallow,
Organic solvents such as senkyu, senburi, thyme, touki, spruce, birch, horsetail, loofah, horse chestnut, yukinoshita, arnica, lily, mugwort, peony, aloe, gardenia, sawara, alcohol, polyhydric alcohol, water,
Natural extracts extracted with aqueous alcohol and the like; pigments; sorbitan monolaurate, sorebitan sesquioleate, sorbitan trioleate, polyoxyethylene sorbitan monolaurate, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol diester, lauroyl diethanol amide , Nonionic surfactants such as fatty acid isopropanol amide, maltitol hydroxyaliphatic ether, alkylated polysaccharides, alkyl glucosides and sugar esters; cationic surfactants such as stearyl trimethyl ammonium chloride, benzalkonium chloride and lauryl amine oxide; palmitin Sodium acid salt, sodium laurate, potassium lauryl sulfate, triethanolamine alkyl sulfate, funnel oil Linear dodecylbenzene sulfate, polyoxyethylene hardened castor oil maleic acid, anionic surfactants such as acyl methyl taurine; perfumes; can be blended purified water.

[0026]

EXAMPLES Next, the present invention will be described in more detail by way of examples, which should not be construed as limiting the invention thereto. In addition, all compounding amounts represent% by weight.

Prior to the examples, the test method used in the present invention,
The evaluation method will be described.

[Whitening Effect Test by Accumulation, etc.] A group of 20 test subjects suffering from black and white, stains, freckles, etc. was prepared.
Example product and comparative example product having the formulation shown in 3 are prepared in the morning and evening, respectively.
It was applied to the face every day for a month, and its whitening effect was examined at the third month. The judgment was evaluated according to the following criteria as the actual feeling of the effect of the subject. (Judgment Criteria) Remarkable effect: Pigmentation seemed to be almost inconspicuous Effective: Very thin, slightly effective: Somewhat thin, ineffective: No change was observed (Evaluation) ⊚: 80% or more of the subjects who evaluated excellent, effective, and slightly effective ○: 50 to less than 80% of the subjects who evaluated excellent, effective, and slightly effective Δ: excellent, effective , And less than 30% to 50% of the subjects evaluated to be slightly effective X: less than 30% to the subjects evaluated to be markedly effective, effective, and slightly effective.

[Dullness-improving effect test] A group of 20 subjects suffering from dull skin was made into 20 subjects, and the products of Examples and Comparative Examples shown in Tables 1 and 2 were applied to the face every day in the morning and evening for 3 months, respectively.
The effect of improving dullness was examined at 3 months. The judgment was evaluated according to the following criteria as the actual feeling of the effect of the subject. (Judgment criteria) Remarkable effect: Dullness is hardly felt Effective: Dullness is hardly felt somewhat Effective: Dullness is not felt a little Invalid: No change (Evaluation) ◎: Remarkable, effective, and slightly effective 80% or more of the evaluated subjects ○: less than 50 to 80% of the subjects who evaluated excellent, effective, and slightly effective Δ: 30 to less than 50% of the subjects who evaluated excellent, effective, and slightly effective X: Less than 30% of the subjects evaluated to be markedly effective, effective, and slightly effective.

Example 1, Comparative Examples 1 to 3 (Lotion) Lotions having the formulations shown in Table 1 below were prepared by a conventional method. Using this, the whitening effect and the dullness improving effect were evaluated by the above test methods.

[0031]

[Table 1] As is clear from Table 1, the lotion of this example has an excellent whitening effect and an extremely excellent dullness improving effect as compared with the comparative example.

Example 2, Comparative Examples 4 to 6 (Cream) Creams having the formulations shown in Table 2 below were prepared by a conventional method. Using this, the whitening effect and the dullness improving effect were evaluated by the above test methods.

[0033]

[Table 2] As is clear from Table 2, the cream whitening effect of this example is superior to that of the comparative example, and an extremely excellent dullness improving effect is obtained.

Examples 3 to 9 (Emulsion) Emulsions having the formulations shown in Table 3 below were prepared. Specifically, 7
The oil phase heated and melted at 70 ° C. was added to the 0 ° C. aqueous phase, preliminary emulsification was performed, and further homogenized with a homokimizer. This was cooled to 30 ° C. to obtain an emulsion. Using this, the whitening effect and the dullness improving effect were evaluated by the above test methods. The results are shown in Table 3.

[0035]

[Table 3] Example 10 (Cream) (Ingredient) (wt%) Oil phase Squalane 10.0 Stearic acid 2.0 Vaseline 2.0 Cetanol 1.0 Lanolin alcohol 2.0 Liquid paraffin 8.0 Preservative 0.2 Perfume 0 .05 aqueous phase carboxyvinyl polymer 0.2 chondroitin sulfate sodium 1.0 .gamma.-butyrobetaine 1.0 hydroquinone-beta-D-xylose 10.0 potassium hydroxide 0.06 purified water balance unit preparation 70 ° C. 70 in the aqueous phase of the The oil phase heated and melted at ℃ was added, preliminarily emulsified, and further homogenized with a homomixer. This was cooled to 30 ° C to obtain an emulsion.

Example 11 (Mask) (Ingredient) (% by weight) Dipropylene glycol phase Dipropylene glycol 3.0 Methylcellulose 0.05 Preservative 0.2 Aqueous phase Carboxyvinyl polymer 0.5 γ-Butyrobetaine 0.5 Hydroquinone-β-D-glucosamine 1.0 Potassium hydroxide 0.15 Purified water Residual manufacturing method After heating and melting the preservative in dipropylene glycol, methylcellulose is added to prepare a dipropylene glycol phase, and A desired mask was obtained by adding carboxyvinyl polymer dissolved in some purified water and γ-butyrobetaine and potassium hydroxide dissolved in other purified water.

The external preparations for skin of Examples 10 and 11 were all excellent in whitening effect and dullness improving effect.

[0038]

INDUSTRIAL APPLICABILITY As described in detail above, according to the present invention, by containing a low molecular weight betaine and a hydroquinone glycoside, a synergistic effect of both is excellent in a whitening effect and an extremely excellent dullness improving effect. An effect is provided that a skin external preparation having the following is provided.

─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. ⁶ Identification code Internal reference number FI Technical display location A61K 31/205 ADA A61K 31/205 ADA 31/70 31/70

Claims (13)

[Claims] 1. A low molecular weight betaine and the following general formula (I): (Wherein, R is a pentose residue, a hexose residue, an amino sugar residue,
A skin external preparation containing a glycoside of hydroquinone represented by a uronic acid residue or a methylated product thereof. 2. The low-molecular-weight betaine is represented by the following general formula (II): (In the formula, R ¹ , R ² and R ³ each independently represent an alkyl group having 1 to 6 carbon atoms; n represents 0 or a positive integer; provided that the carbon number of R ¹ , R ² and R ³ is And the sum of n is 8 or less), the external preparation for skin according to claim 1, which is a quaternary ammonium salt. 3. The external skin preparation according to claim 2, wherein R ¹ , R ² and R ^{3 in the} general formula (II) are all methyl groups. 4. In the general formula (II), n is 0 or 2
The external preparation for skin according to claim 2 or 3, which is 5. In the general formula (I), R is any one or more of L-arabinose, D-arabinose, D-xylose, D-ribose, L-xylose, L-lyxose and D-ribulose. The external preparation for skin according to any one of claims 1 to 4, which is a pentose residue or a methylated product thereof. 6. In the general formula (I), R is D-glucose, D-galactose, L-galactose, D-mannose, D-talose, D-fructose, L-sorbose, D-tagatose, D-busicose. One of
Is a hexose or more saccharide residue or a methylated product thereof,
The external preparation for skin according to any one of claims 1 to 4. 7. In the general formula (I), R is any one or more amino sugar residues selected from D-glucosamine, D-galactosamine, sialic acid, aminouronic acid and muramic acid, or a methylated product thereof. The external preparation for skin according to any one of claims 1 to 4. 8. In the general formula (I), R is at least one uronic acid selected from D-glucuronic acid, D-galacturonic acid, D-mannuronic acid, L-iduronic acid and L-guluronic acid. 2. A residue or a methylated product thereof.
The external preparation for skin according to any one of 1 to 4. 9. The external skin preparation according to claim 1, wherein the glycoside of hydroquinone represented by the general formula (I) is hydroquinone-D-glucose. 10. The external preparation for skin according to claim 1, which comprises 0.01 to 30% by weight of low-molecular-weight betaine in the total amount of the external preparation for skin. 11. The external preparation for skin according to any one of claims 1 to 9, which comprises 0.1 to 10% by weight of low-molecular-weight betaine in the total amount of the external preparation for skin. 12. The hydroquinone glycoside represented by the general formula (I) is contained in an amount of 0.1 to 30% by weight in the total amount of the external preparation for skin, according to any one of claims 1 to 11. The skin external preparation described. 13. The method according to claim 1, wherein the hydroquinone glycoside represented by the general formula (I) is contained in an amount of 1 to 20% by weight based on the total amount of the skin external preparation. External skin preparation.